IndieBio

Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.

BioLattice is a biotechnology company focused on developing tissue-engineered cornea technology. Their primary goal is to provide a viable alternative to donor tissue for full-thickness corneal transplants. The company's innovative technology offers a corneal prototype with vision-correcting capabilities, aiming to restore sight for patients requiring corneal transplants.

FREZENT is a biotechnology company focused on developing innovative therapeutics for advanced-stage cancer patients. It specializes in creating biological inhibitors that target cancer-specific lipid metabolism, aiming to prevent the reactivation of dormant cancer cells.

BioLattice is a biotechnology company focused on developing tissue-engineered cornea technology. Their primary goal is to provide a viable alternative to donor tissue for full-thickness corneal transplants. The company's innovative technology offers a corneal prototype with vision-correcting capabilities, aiming to restore sight for patients requiring corneal transplants.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.

Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.

FREZENT is a biotechnology company focused on developing innovative therapeutics for advanced-stage cancer patients. It specializes in creating biological inhibitors that target cancer-specific lipid metabolism, aiming to prevent the reactivation of dormant cancer cells.

Care Constitution operates a telehealth platform that facilitates remote medical consultations. It uses AI to analyze sound and images during virtual appointments, generating real-time clinical data and automated assessments for healthcare providers.

Cybele Microbiome is a biotechnology company focused on enhancing skin health through precision control of the microbiome. The company utilizes a proprietary AI platform that integrates machine learning with advanced biotechnology and unique data sources to identify natural prebiotics. These prebiotics are designed to nourish the microbiome, leading to the development of customized skincare products. By employing genetic sequencing methods and sustainable nutrient sources, Cybele Microbiome aims to strengthen the skin's natural barrier and promote overall health and longevity. The innovative approach combines artificial intelligence with microbiome science to revolutionize skincare, enabling consumers to maintain the integrity of their skin through effective and conscientious skincare solutions.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Aima is a Vancouver-based company founded in 2019 that focuses on transforming the management of menstrual pain. The company provides a weekly proactive pain management system designed specifically for menstruators, offering personalized and effective solutions to address period pain. Aima's platform aims to empower users by enabling them to manage their pain with greater freedom and dignity. Through its innovative approach, Aima seeks to improve the overall experience of menstruators by providing accessible and tailored pain relief options.

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.

Eachday is a Pittsburgh-based digital health management company focused on providing tools and evidence-based techniques for self-managing ADHD. The company offers an ADHD self-management application designed to assist users in effectively managing their daily lives. By tracking behaviors and interests, such as task completion, cognitive failures, and self-reported symptoms, Eachday creates personalized profiles that help users gain insights into their cognitive patterns. This approach enables individuals to visualize their time and develop structured routines, ultimately aiming to alleviate ADHD symptoms as they arise and lessen the cognitive burden associated with everyday activities.

Eachday is a Pittsburgh-based digital health management company focused on providing tools and evidence-based techniques for self-managing ADHD. The company offers an ADHD self-management application designed to assist users in effectively managing their daily lives. By tracking behaviors and interests, such as task completion, cognitive failures, and self-reported symptoms, Eachday creates personalized profiles that help users gain insights into their cognitive patterns. This approach enables individuals to visualize their time and develop structured routines, ultimately aiming to alleviate ADHD symptoms as they arise and lessen the cognitive burden associated with everyday activities.

Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.

Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.

Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.

Cybele Microbiome is a biotechnology company focused on enhancing skin health through precision control of the microbiome. The company utilizes a proprietary AI platform that integrates machine learning with advanced biotechnology and unique data sources to identify natural prebiotics. These prebiotics are designed to nourish the microbiome, leading to the development of customized skincare products. By employing genetic sequencing methods and sustainable nutrient sources, Cybele Microbiome aims to strengthen the skin's natural barrier and promote overall health and longevity. The innovative approach combines artificial intelligence with microbiome science to revolutionize skincare, enabling consumers to maintain the integrity of their skin through effective and conscientious skincare solutions.

Ivy Natal is a biotechnology company focused on addressing infertility through innovative reproductive solutions. The company has developed a skin biopsy technology that enables the creation of human egg cells from skin samples. This process activates the existing DNA within skin cells to transform them into healthy egg cells, offering a novel alternative to traditional in vitro methods for producing eggs and sperm. By circumventing the challenges associated with conventional reproductive techniques, Ivy Natal aims to provide couples, including those in same-sex relationships, with the opportunity to have genetically related children.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Beeline Therapeutics is an early-stage preclinical cell therapy company focused on developing next-generation immune cell therapies for immune-mediated diseases, where the body's immune cells mistakenly attack healthy tissue. The company specializes in genetically engineering a patient's own immune cells, specifically Regulatory T cells, to secrete therapeutic proteins in vivo and promote tolerance. By enhancing the function of these re-engineered Tregs, Beeline aims to produce optimal quantities of immunomodulatory cytokines, antibodies, and other therapeutic proteins. Additionally, the company is working on improving antigen specificity through targeting receptors, which aids in better localization of these engineered cells within the body, ultimately contributing to the advancement of innovative treatments for immune-mediated human diseases.

11 Biomics LLC, headquartered in Albuquerque, New Mexico, is a biotechnology company specializing in the development of biological therapeutics for the cannabis industry. The company focuses on providing treatments and protection against fungal and bacterial diseases affecting both cannabis and hemp plants. 11 Biomics operates at various scales to address these issues, aiming to support the health and productivity of cannabis crops.

EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Nivien Therapeutics is a biomedical company focused on developing medicines that enhance chemotherapy and immunotherapy for treatment-resistant cancers. Founded in 2016 and based in Boston, Massachusetts, the company has developed first small-molecule inhibitors targeting the Hippo signaling pathway, a mechanism implicated in cancer resistance. Its program aims to de-risk transfers of technology assets from leading research institutes and to build a platform that advances IO-chemo combination therapies, with an emphasis on expanding options for patients who do not respond to standard treatments.

Proteorex Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutics for diseases with significant unmet medical needs. Founded in 2014 and based in Toronto, Canada, the company specializes in manufacturing small molecule drugs that target challenging diseases. Utilizing a proprietary platform technology, Proteorex integrates novel synthesis design strategies, computational modeling, and patient-derived cell-based screening to identify and develop new lead compounds. This approach enables the company to unlock druggable targets that have previously been considered undruggable, particularly in the field of oncology. Proteorex also maintains an office in San Francisco, further enhancing its capabilities in drug discovery and development.

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.